Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06539429
PHASE1
Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L
Sponsor: Anterogen Co., Ltd.
View on ClinicalTrials.gov
Summary
This is a phase I open study to evaluate the efficacy and safety of ANT-301 in patients with knee osteoarthritis K\&L Grade III/IV.
Official title: Phase I Clinical Study to Evaluate Safety and Efficacy of ANT-301 in Knee Osteoarthritis Patients
Key Details
Gender
All
Age Range
19 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2024-10-22
Completion Date
2026-05-15
Last Updated
2025-09-22
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
ANT-301
Administration on Day 1
Locations (1)
Seoul National University
Seoul, Seoul, South Korea